Search Results 1271-1280 of 4288 for 搜索痕迹咨询邮箱:lgooxc@hotmail.com
About this study. The purpose of this study is to identify the burden of Cough Hypersensitivity Syndrome (CHS) diagnosis made after a comprehensive ...
Dr. Cerhan's team in the Lymphoma Epidemiology Lab at Mayo Clinic has expertise in cancer epidemiology, hematology, immunology, laboratory medicine and ...
Projects in Mayo Clinic's Aging and Dementia Imaging Research (ADIR) Lab focus on neuroimaging to diagnose Alzheimer's disease and related dementias before ...
The aim of PERKA-812-003 study is to investigate the safety, pharmacokinetics and preliminary anti-tumor activity of treatment with NMS-03597812 as single agent ...
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024).
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
His lab is also involved with regenerative medicine of liver disease as it pertains to treating patients in liver failure with extracorporeal bioartificial ...
About this study. The primary hypothesis of the study is that treatment with either once-daily or twice-daily pacritinib results in a greater proportion of ...
This is a prospective, multi-center, non-randomized clinical evaluation utilizing the PulseRider® Aneurysm Neck Reconstruction Device. Participation eligibility.
Ixazomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving cyclophosphamide together with ixazomib and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.